<https://www.medicalpress.es/#/schema/person/image/>
<http://schema.org/contentUrl>
<https://secure.gravatar.com/avatar/6d807bfc3d35c3bbf46846ec9702c1ee?s=96&d=blank&r=g>
<https://www.medicalpress.es/mas-de-un-tercio-de-pacientes-con-leucemia-de-alto-riesgo-responden-a-un-nuevo-farmaco-experimental/>